Medical Communications

A report from the BBC has found that 505 registered organ donors had their decision blocked by relatives, over the …

Peter Naredi, of ECCO, explores how a multi-dimensional approach is necessary to ensure that patients receive access to the most …

All has been quiet since former Biogen CEO, George Scangos, departed the company and then set up Vir Biotechnology in …

Two studies published separately by the BBC and the Care Quality Commission (CQC) point to growing problems across NHS services …

It was a mixed bag for Johnson & Johnson on its announcement of third quarter results. It could largely be …

  In an unprecedented move, leading global pharmaceutical company Allergan appears to have handed its Orange Book-listed US patents covering …

The EMA received a broadside just less than two week ago from a group of researchers that had studied data …

Sanofi Aventis Nigeria plans to put together a National Diabetes Summit to address crisis in the country as five million …

Are our pharmacovigilance measures as effective as we think? And why is it important to answer that question, especially now? …

It’s always crunch time for regulatory operations. Whether you’re managing plans and documents for an upcoming IND or producing routine product variations, …

It’s been another packed week in the industry, with one of the biggest takeaways being that childhood obesity has rocketed …

The results of a study from the University of California, San Francisco will be welcomed with a certain excitement from …

Following on from the popularity of our previous free webinar sessions, Pharmafocus is once again partnering with PrimeVigilance to bring you an overview of the EudraVigilance changes and their impact on MAHs.

A vaccine for leprosy, developed by the Infectious Disease Research Institute (IDRI) and with the financial support of the American …

MSD, known as Merck in North America, has revealed that it will not pursue a regulatory filing for its cholesterol …